Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
Phase 1
Recruiting
- Conditions
- Advanced Malignant Solid NeoplasmClinical Stage IV Gastroesophageal Junction AdenocarcinomaClinical Stage IVB Gastroesophageal Junction Adenocarcinoma ALocally Advanced Colorectal CarcinomaLocally Advanced Gastroesophageal Junction AdenocarcinomaPostneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
- Interventions
- First Posted Date
- 2020-08-12
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 45
- Registration Number
- NCT04511039
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy
Phase 4
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-08-06
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 89
- Registration Number
- NCT04502095
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers
Early Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-07-23
- Last Posted Date
- 2023-06-06
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 130
- Registration Number
- NCT04484532
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients
- First Posted Date
- 2020-05-07
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 64
- Registration Number
- NCT04379518
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Consumer Assessment of Tobacco Flavor and Odor
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 70
- Registration Number
- NCT04358315
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 23
- Registration Number
- NCT04348747
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia, United States
A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence
Early Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-03-06
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 60
- Registration Number
- NCT04298606
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2023-04-10
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 174
- Registration Number
- NCT04297384
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Episodic Future Thinking and Future Thinking Priming for Smoking Cessation
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 26
- Registration Number
- NCT04297332
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Web-Based Lifestyle Intervention for the Improvement of Health in African American Cancer Survivors
Not Applicable
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2020-03-02
- Last Posted Date
- 2023-04-27
- Lead Sponsor
- Roswell Park Cancer Institute
- Registration Number
- NCT04290962
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
© Copyright 2024. All Rights Reserved by MedPath